Completed PHASE3 NCT00309543

Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B

A Prospectively Randomized Study on Adjuvant Chemotherapy in Patients With Operated Colon Carcinoma Dukes B (Stage II; T3-4, N0, M0).

Sponsor: Austrian Breast & Colorectal Cancer Study Group

Conditions Colon Cancer Stage II

Interventions Fluorouracil Leucovorin

Updated 5 times since 2017 Last updated: Mar 31, 2006 Started: Nov 30, 1993

This PHASE3 trial investigates Colon Cancer Stage II and is currently completed. Austrian Breast & Colorectal Cancer Study Group leads this study, which shows 5 recorded versions since 1993 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2017 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Nov 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Austrian Breast & Colorectal Cancer Study Group

Data source: Austrian Breast & Colorectal Cancer Study Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Feldkirch, Austria , Graz, Austria , Güssing, Austria , Hainburg an der Donau, Austria , Kirchdorf, Austria , Krems, Austria , Leoben, Austria , Oberpullendorf, Austria , Saint Veit A. D. Glan, Austria , Salzburg, Austria and 7 more locations